1. Assessment of Blood Biomarker Profile After Acute Concussion During Combative Training Among US Military Cadets: A Prospective Study From the NCAA and US Department of Defense CARE Consortium
- Author
-
Biomedical Engineering and Mechanics, Giza, Christopher C., McCrea, Michael A., Huber, Daniel L., Cameron, Kenneth L., Houston, Megan N., Jackson, Jonathan C., McGinty, Gerald T., Pasquina, Paul, Broglio, Steven P., Brooks, M. Alison, DiFiori, John P., Duma, Stefan M., Harezlak, Jaroslaw, Goldman, Joshua T., Guskiewicz, Kevin M., McAllister, Thomas W., McArthur, David, Meier, Timothy B., Mihalik, Jason P., Nelson, Lindsay D., Rowson, Steven, Gill, Jessica M., Biomedical Engineering and Mechanics, Giza, Christopher C., McCrea, Michael A., Huber, Daniel L., Cameron, Kenneth L., Houston, Megan N., Jackson, Jonathan C., McGinty, Gerald T., Pasquina, Paul, Broglio, Steven P., Brooks, M. Alison, DiFiori, John P., Duma, Stefan M., Harezlak, Jaroslaw, Goldman, Joshua T., Guskiewicz, Kevin M., McAllister, Thomas W., McArthur, David, Meier, Timothy B., Mihalik, Jason P., Nelson, Lindsay D., Rowson, Steven, and Gill, Jessica M.
- Abstract
Importance Validation of protein biomarkers for concussion diagnosis and management in military combative training is important, as these injuries occur outside of traditional health care settings and are generally difficult to diagnose. Objective To investigate acute blood protein levels in military cadets after combative training-associated concussions. Design, Setting, and Participants This multicenter prospective case-control study was part of a larger cohort study conducted by the National Collegiate Athletic Association and the US Department of Defense Concussion Assessment Research and Education (CARE) Consortium from February 20, 2015, to May 31, 2018. The study was performed among cadets from 2 CARE Consortium Advanced Research Core sites: the US Military Academy at West Point and the US Air Force Academy. Cadets who incurred concussions during combative training (concussion group) were compared with cadets who participated in the same combative training exercises but did not incur concussions (contact-control group). Clinical measures and blood sample collection occurred at baseline, the acute postinjury point (<6 hours), the 24- to 48-hour postinjury point, the asymptomatic postinjury point (defined as the point at which the cadet reported being asymptomatic and began the return-to-activity protocol), and 7 days after return to activity. Biomarker levels and estimated mean differences in biomarker levels were natural log (ln) transformed to decrease the skewness of their distributions. Data were collected from August 1, 2016, to May 31, 2018, and analyses were conducted from March 1, 2019, to January 14, 2020. Exposure Concussion incurred during combative training. Main Outcomes and Measures Proteins examined included glial fibrillary acidic protein, ubiquitin C-terminal hydrolase-L1, neurofilament light chain, and tau. Quantification was conducted using a multiplex assay (Simoa; Quanterix Corp). Clinical measures included the Sport Concussion Assessment
- Published
- 2021